Clinical Trial Update: Semaglutide in CFRD [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial evaluating semaglutide in cystic fibrosis-related diabetes has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis
• Cystic Fibrosis-related Diabetes

Drugs mentioned

• semaglutide (semaglutide)

Snippet

Sponsor: University of Minnesota | Conditions: Cystic Fibrosis, Cystic Fibrosis-related Diabetes | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2026-01-21